Back
The Goldman Sachs Group Vs. Insmed Industry Stock Comparison
Sell
48
GS
The Goldman Sachs Group
Last Price:
495.29
Seasonality Move:
9.56%
Buy
61
INSM
Insmed
Last Price:
72.22
Seasonality Move:
4.27%
Sell
48
The Goldman Sachs Group (GS)
is a Sell
Is The Goldman Sachs Group a Buy, Sell or Hold?
- The current The Goldman Sachs Group [GS] share price is $495.16. The Score for GS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- GS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $72.28. The Score for INSM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GS Stock Price Chart
What is The Goldman Sachs Group's stock price today?
-
The The Goldman Sachs Group share price today is $495.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GS is experiencing buying pressure, which is a positive indicator for future bullish movement.
INSM Stock Price Chart
GS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 52.54 | Buy |
| Chaikin Money Flow: | 1331257 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (479.51 - 499.19) | Buy |
| Bollinger Bands (100): | (459.74 - 497.78) | Buy |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 46.34 | Sell |
| Chaikin Money Flow: | 515638 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.86 - 74.32) | Sell |
| Bollinger Bands (100): | (51.81 - 81.07) | Buy |
GS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 493.14 | Buy |
| 20-day SMA: | 488.89 | Buy |
| 50-day SMA: | 492.06 | Buy |
| 200-day SMA: | 438.21 | Buy |
| 8-day EMA: | 492.5 | Buy |
| 20-day EMA: | 491.94 | Buy |
| 50-day EMA: | 488.2 | Buy |
| 200-day EMA: | 443.7 | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.58 | Sell |
| 20-day SMA: | 72.92 | Sell |
| 50-day SMA: | 73.99 | Sell |
| 200-day SMA: | 47.03 | Buy |
| 8-day EMA: | 72.53 | Sell |
| 20-day EMA: | 73.04 | Sell |
| 50-day EMA: | 71.92 | Buy |
| 200-day EMA: | 53.13 | Buy |
The Goldman Sachs Group Earnings Growth & GS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.13 per share, and an increase next year of $4.67 per share.
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $1.08 per share.
The Goldman Sachs Group Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||